SEC Filing Summary: 180 Life Sciences Corp.
Business Context and Reporting Period
This Form 8-K was filed by 180 Life Sciences Corp. (not Forum Markets Inc.) on December 6, 2021. The registrant is a Delaware corporation with principal executive offices in Palo Alto, California. The filing serves as a Regulation FD disclosure providing follow-up information regarding the Company's phase 2b clinical trial results for dupuytren's disease, originally disclosed on December 1, 2021.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on clinical trial updates and does not contain financial statements or operational financial data.
Material Changes
The material event reported is the issuance of a press release (Exhibit 99.1) containing follow-up details on the phase 2b clinical trial for dupuytren's disease. No financial material changes versus prior periods are reported in this document.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The press release furnished with this filing contains forward-looking statements regarding future financial performance, events, and trends. These are subject to known and unknown risks and uncertainties.
- Risk Factors: The Company notes that actual results may differ materially from projected statements. Detailed risk factors are referenced in the Company's periodic filings (Form 10-Q and Form 10-K).
- Legal Disclaimer: The information in Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings except as expressly set forth.
Investor Verification Checklist
- Verify the specific clinical trial data and follow-up information in Exhibit 99.1 (Press Release dated December 6, 2021), as the 8-K text only summarizes the disclosure.
- Confirm the Company's ticker symbols: ATNF (Common Stock) and ATNFW (Warrants) on The NASDAQ Stock Market LLC.
- Review the Company's most recent Form 10-Q or Form 10-K for actual financial metrics, as this 8-K contains no financial data.
- Note the discrepancy in the request metadata: The filing is for 180 Life Sciences Corp., not Forum Markets Inc.